Psychotic Disorders - Philippines

Revenue in the Psychotic Disorders market is projected to reach US$30.56m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.61%, resulting in a market volume of US$31.51m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$39.31 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Philippines is experiencing significant growth due to various factors.

Customer preferences: Customers in the Philippines are increasingly seeking treatment for psychotic disorders, leading to a growing demand for medications and therapies. This can be attributed to several factors. Firstly, there is a growing awareness and understanding of mental health issues in the country, leading to more individuals seeking help for their conditions. Additionally, the stigma surrounding mental health is gradually decreasing, making it easier for people to openly discuss and seek treatment for psychotic disorders.

Trends in the market: One of the key trends in the Psychotic Disorders market in Philippines is the increasing use of antipsychotic medications. These medications are commonly prescribed to manage symptoms of psychotic disorders and are becoming more widely available in the country. The market is also witnessing a shift towards personalized medicine, with healthcare providers tailoring treatment plans to individual patients based on their specific needs and responses to different medications. This trend is driven by advancements in genetic testing and the growing understanding of the genetic factors that contribute to psychotic disorders.Another trend in the market is the integration of technology into the treatment of psychotic disorders. Digital platforms and mobile applications are being developed to support individuals with psychotic disorders in managing their symptoms and improving their overall well-being. These technologies provide tools for self-monitoring, psychoeducation, and connecting with healthcare professionals, enhancing the accessibility and effectiveness of treatment options.

Local special circumstances: The Philippines has a relatively high prevalence of psychotic disorders compared to other countries in the region. This can be attributed to various factors, including the high levels of stress and urbanization in cities, which can contribute to the development of mental health conditions. Additionally, the country has a large population, which further increases the demand for mental health services.

Underlying macroeconomic factors: The growing Psychotic Disorders market in Philippines is also influenced by underlying macroeconomic factors. The country's economy has been experiencing steady growth, leading to an increase in disposable income among the population. This allows individuals to afford the cost of treatment and medication for psychotic disorders. Furthermore, the government has been investing in the healthcare sector, including mental health services, which has contributed to the expansion and improvement of treatment options available to individuals with psychotic disorders.In conclusion, the Psychotic Disorders market in Philippines is experiencing growth due to increasing customer preferences for treatment, the adoption of new trends such as personalized medicine and technology integration, local special circumstances such as high prevalence rates, and underlying macroeconomic factors such as economic growth and government investment in healthcare.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.